D. E. Shaw & Co., Inc. Ovid Therapeutics Inc. Transaction History

D. E. Shaw & Co., Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.72 - $4.04 $19,048 - $28,292	-7,003 Reduced 8.95%	71,264 $217,000
Q4 2023 Feb 14, 2024	SELL	$2.98 - $3.78 $18,002 - $22,834	-6,041 Reduced 7.17%	78,267 $252,000
Q3 2023 Nov 14, 2023	SELL	$3.23 - $3.97 $74,206 - $91,206	-22,974 Reduced 21.41%	84,308 $323,000
Q2 2023 Aug 14, 2023	SELL	$2.53 - $3.89 $586,651 - $902,005	-231,878 Reduced 68.37%	107,282 $351,000
Q1 2023 May 15, 2023	SELL	$1.88 - $2.85 $314,273 - $476,425	-167,167 Reduced 33.02%	339,160 $875,000
Q4 2022 Feb 14, 2023	SELL	$1.43 - $1.89 $264,544 - $349,642	-184,996 Reduced 26.76%	506,327 $941,000
Q3 2022 Nov 14, 2022	SELL	$1.84 - $2.26 $364,395 - $447,572	-198,041 Reduced 22.27%	691,323 $1.27 Million
Q2 2022 Aug 15, 2022	BUY	$1.69 - $3.31 $1,120 - $2,194	663 Added 0.07%	889,364 $1.91 Million
Q1 2022 May 16, 2022	BUY	$2.65 - $3.49 $343,453 - $452,321	129,605 Added 17.07%	888,701 $2.79 Million
Q4 2021 Feb 14, 2022	BUY	$3.13 - $3.73 $94,419 - $112,519	30,166 Added 4.14%	759,096 $2.44 Million
Q3 2021 Nov 15, 2021	SELL	$3.31 - $4.04 $56,220 - $68,619	-16,985 Reduced 2.28%	728,930 $2.45 Million
Q2 2021 Aug 16, 2021	BUY	$3.3 - $4.49 $528,693 - $719,342	160,210 Added 27.35%	745,915 $2.92 Million
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $903,415 - $1.67 Million	373,312 Added 175.76%	585,705 $2.36 Million
Q4 2020 Feb 16, 2021	BUY	$2.28 - $6.84 $484,256 - $1.45 Million	212,393 New	212,393 $490,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.